ZyVersa Therapeutics, Inc. Profile Avatar - Palmy Investing

ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segm…

Biotechnology
US, Weston [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of ZVSA's Analysis
CIK: - CUSIP: - ISIN: US98987D2018 LEI: - UEI: -
Secondary Listings
ZVSA has no secondary listings inside our databases.